We evaluated the evidence about whether granulocyte transfusions given to prevent infection are safe and decrease the risk of infection. Our target population was people with neutropenia (a very low ...
Bacterial and fungal infections are the main cause of morbidity and mortality in neutropenic patients. The transfusion of granulocytes to restore host defenses in severely neutropenic patients has ...
Assessment of weight change and BMI as prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in a Polish female cohort. A phase I/II study evaluating the safety and ...
Basophils are the rarest type of white blood cell (WBC). Sometimes called granulocytes, the cells hold tiny granules full of histamine. Basophils can also trigger your allergic reaction. They can ...
Granulocytes should be transfused ABO- and Rhesus-compatible as there is always a significant RBC contamination. If the recipient is cytomegalo virus-negative concentrates from cytomegalo ...
Immature ganulocytes, also called myeloblasts, are a type of young white blood cell. Unusual amounts of myeloblasts usually occur due to problems with bone marrow, such as certain types of blood ...
Granulocytes are white blood cells that contain granules. There are three types — neutrophils, basophils, and eosinophils. These granules contain enzymes that enable these cells to kill bacteria and ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Myeloblasts are precursors to specific types of white blood cells that help your body fight infections. Too many myeloblasts may be a sign of a blood cancer like leukemia. Myeloblasts, or blast cells, ...
How does G-CSF work? Growth factors are proteins made in the body. Some of them make the bone marrow produce blood cells. G-CSF is a type of growth factor that makes the bone marrow produce more white ...
—These findings suggest that clone size at PNH onset may serve as a prognostic factor for disease burden and MAVEs/TEs, aiding in clinical decision-making about treatment initiation or maintenance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results